SCM
Suvretta Capital Management’s Royalty Pharma RPRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-1,866,361
| Closed | -$52.8M | – | 108 |
|
|
2024
Q3 | $52.8M | Hold |
1,866,361
| – | – | 1.69% | 19 |
|
|
2024
Q2 | $49.2M | Sell |
1,866,361
-384,000
| -17% | -$10.1M | 1.81% | 17 |
|
|
2024
Q1 | $68.3M | Sell |
2,250,361
-1,637,341
| -42% | -$49.7M | 2.54% | 9 |
|
|
2023
Q4 | $109M | Sell |
3,887,702
-208,043
| -5% | -$5.84M | 4.94% | 3 |
|
|
2023
Q3 | $111M | Buy |
4,095,745
+1,048,696
| +34% | +$28.5M | 6.01% | 1 |
|
|
2023
Q2 | $93.7M | Hold |
3,047,049
| – | – | 5.01% | 1 |
|
|
2023
Q1 | $110M | Buy |
3,047,049
+1,072,424
| +54% | +$38.6M | 4.64% | 1 |
|
|
2022
Q4 | $78M | Buy |
1,974,625
+131,907
| +7% | +$5.21M | 3.28% | 9 |
|
|
2022
Q3 | $74M | Sell |
1,842,718
-1,235,788
| -40% | -$49.7M | 3.07% | 9 |
|
|
2022
Q2 | $129M | Buy |
3,078,506
+1,052,896
| +52% | +$44.3M | 4.92% | 1 |
|
|
2022
Q1 | $78.9M | Buy |
2,025,610
+58,337
| +3% | +$2.27M | 2.41% | 16 |
|
|
2021
Q4 | $78.4M | Buy |
1,967,273
+439,373
| +29% | +$17.5M | 1.52% | 25 |
|
|
2021
Q3 | $55.2M | Buy |
1,527,900
+798,523
| +109% | +$28.9M | 0.93% | 32 |
|
|
2021
Q2 | $29.9M | Sell |
729,377
-227,676
| -24% | -$9.33M | 0.45% | 50 |
|
|
2021
Q1 | $41.7M | Sell |
957,053
-2,599,880
| -73% | -$113M | 0.62% | 40 |
|
|
2020
Q4 | $178M | Buy |
3,556,933
+744,552
| +26% | +$37.3M | 2.54% | 15 |
|
|
2020
Q3 | $118M | Buy |
2,812,381
+659,381
| +31% | +$27.7M | 2.13% | 19 |
|
|
2020
Q2 | $105M | Buy |
+2,153,000
| New | +$105M | 2.25% | 16 |
|